Figure 1.
CXXC5 expression is increased in 4T1-derived metastatic cancer compared to primary cancer. (A) Expression value of CXXC5 in 4T1-derived metastatic cancer, compared with primary breast cancer, through data analysis of GDS5666. Student's t-test; *P<0.05. The Kaplan-Meier curve of breast cancer with (B) MR-free (C) and AE-free CXXC5 expression. Data were obtained and analysed by using bc-GenExMiner v4.0. (D) Box plot of CXXC5 mRNA expression according to PAM50 subtype in bc-GenExMiner v4.0. Dunnett-Tukey-Kramer's test; **P<0.0001. CXXC5, CXXC finger protein 5; MR, metastatic relapse; AE, any event.